About this trial
This is a monocentric cohort study conducted in the cardiology department of Nancy hospital. The main purpose of the study is to document the global management strategy of patients hospitalized for heart failure and evaluate the association between patient's care and post-hospitalization outcome.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Man or women ≥ 18 years
Patients hospitalized for cardiac decompensation (ESC 2016 and 2021 criteria)
Disqualifiers
Patient expressing refusal to participate in research
Patient who is a minor or under administrative protection
Pregnant women
Patient with ventricular assistance
Trial population
Patients hospitalized for cardiac decompensation in the cardiology department of CHRU of Nancy,
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
All-cause post-hospitalization mortality
Composite endpoint of all-cause post-hospitalization mortality and rehospitalization for heart failure with outcome 2
Rehospitalization for heart failure
Composite endpoint of all-cause post-hospitalization mortality and rehospitalization for heart failure with outcome 1
Secondary outcomes
Percentage of maximum dose of each cardiotropic treatment indicated in heart failure according to ESC recommendations
Influenza and pneumococcal vaccination status
Evolution of renal function
Note: assessed by creatinine levels and GFR by CKD EPI
All-cause Rehospitalization
Assessed by: Rehospitalization for any cause other than hear failure after discharge.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Pr. Nicolas GIRERD
Lead sponsor
Central Hospital, Nancy, France
Sponsor institution